BIZTRAC BETA
Retail sale of medical and orthopaedic goods

ÅSENVEIEN 1 AS

Org. no. 817678572 Limited company (AS) Nordre Follo Incorporated 2016 Active
Ownership graph ↗
Revenue 2024 NOK 243,000
Operating profit NOK 221,000
Equity NOK 598,000
Incorporated 2016
Share capital NOK 50,000

ÅSENVEIEN 1 AS is registered as a limited company in Nordre Follo, Akershus with organisation number 817678572. The business is classified under retail sale of medical and orthopaedic goods (NACE 47.740). The company was incorporated in 2016. Registered share capital is NOK 50,000, divided into 50 shares. The company's stated purpose is: “Selskapets virksomhet er kjøp, salg, utvikling, utleie og drift av fast eiendom, samt investering i aksjer og andeler, og alt som står i forbindelse med dette”. The most recent filed accounts, for the 2024 financial year, show NOK 243,000 in revenue and NOK 221,000 in operating profit.

Key figures · 2024

Revenue
NOK 243,000
Operating profit
NOK 221,000
Equity
NOK 598,000
Est. value
NOK 1.1m

Financial health · 2024

Liquidity
6.40
Very good
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
88.3%
Very good
Equity as a share of total capital

Who owns ÅSENVEIEN 1 AS?

KROOPAS HOLDING AS
ÅSENVEIEN 1 AS
NOK 243,000 rev. · NOK 221,000 profit

ÅSENVEIEN 1 AS has 1 registered shareholder:

All shareholders and roles →

Frequently asked questions about ÅSENVEIEN 1 AS

Who owns ÅSENVEIEN 1 AS?

KROOPAS HOLDING AS is the largest registered owner, with 100.0%.

What is the revenue of ÅSENVEIEN 1 AS?

ÅSENVEIEN 1 AS had revenue of NOK 243,000 in 2024.

Who is the general manager of ÅSENVEIEN 1 AS?

Øyvind Krogh is registered as general manager of ÅSENVEIEN 1 AS.

Where is ÅSENVEIEN 1 AS based?

ÅSENVEIEN 1 AS has its business address in Ski.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.